{"id":"W4403036158","doi":"10.1080/10428194.2024.2402814","title":"Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma","year":2024,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; AbbVie Canada; Pharmacyclics; GlaxoSmithKline; Pfizer","keywords":"Ibrutinib; Chronic lymphocytic leukemia; Medicine; Lymphoma; Internal medicine; Oncology; Leukemia","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002231119,0.0001976705,0.0004287,0.001023781,0.0001792422,0.001219197,0.0003291213,0.0003656627,0.0006101162],"category_scores_gemma":[0.009226916,0.0001493524,0.0005917994,0.00181677,0.0001970016,0.0007324056,0.0004709914,0.0004392951,0.0001139814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009822886,"about_ca_system_score_gemma":0.0004368263,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005907251,"about_ca_topic_score_gemma":0.008241946,"domain_scores_codex":[0.997857,0.001042742,0.0003707078,0.0003159048,0.0002871325,0.0001264846],"domain_scores_gemma":[0.9891317,0.002813315,0.006679734,0.0005135608,0.0005467869,0.0003149431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001165432,0.0001312699,0.9900956,0.00005740855,0.0004317935,0.00006426743,0.0000560751,0.001545274,0.0001322284,0.00006134821,0.0004535882,0.005805696],"study_design_scores_gemma":[0.0002546454,0.0007405002,0.9874095,0.00004517543,0.0003088529,0.0005720333,0.0002991307,0.008174693,0.0003542631,0.0001468172,0.001668974,0.00002538556],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946392,0.0005388086,0.0002797852,0.0001241421,0.000005377531,0.0000324132,0.003886819,0.000009533215,0.000483955],"genre_scores_gemma":[0.9946271,0.0001570088,0.0002826573,0.00007517631,0.00001146915,0.00002797437,0.00476393,0.000002403019,0.00005231797],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005907251,"threshold_uncertainty_score":0.01179945,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01312591007018359,"score_gpt":0.2702881273349522,"score_spread":0.2571622172647686,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}